These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
299 related items for PubMed ID: 21082509
1. Gonadotropin-releasing hormone agonist trigger: the way to eliminate ovarian hyperstimulation syndrome--a 20-year experience. Kol S, Itskovitz-Eldor J. Semin Reprod Med; 2010 Nov; 28(6):500-5. PubMed ID: 21082509 [Abstract] [Full Text] [Related]
2. Ovarian hyperstimulation syndrome prevention strategies: Luteal support strategies to optimize pregnancy success in cycles with gonadotropin-releasing hormone agonist ovulatory trigger. Engmann L, Benadiva C. Semin Reprod Med; 2010 Nov; 28(6):506-12. PubMed ID: 21082510 [Abstract] [Full Text] [Related]
6. GnRHa to trigger final oocyte maturation: a time to reconsider. Humaidan P, Papanikolaou EG, Tarlatzis BC. Hum Reprod; 2009 Oct; 24(10):2389-94. PubMed ID: 19608565 [Abstract] [Full Text] [Related]
7. GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients. Humaidan P, Polyzos NP, Alsbjerg B, Erb K, Mikkelsen AL, Elbaek HO, Papanikolaou EG, Andersen CY. Hum Reprod; 2013 Sep; 28(9):2511-21. PubMed ID: 23753114 [Abstract] [Full Text] [Related]
8. Dual trigger of oocyte maturation with gonadotropin-releasing hormone agonist and low-dose human chorionic gonadotropin to optimize live birth rates in high responders. Griffin D, Benadiva C, Kummer N, Budinetz T, Nulsen J, Engmann L. Fertil Steril; 2012 Jun; 97(6):1316-20. PubMed ID: 22480822 [Abstract] [Full Text] [Related]
12. GnRH agonist trigger and a freeze-all strategy to prevent ovarian hyperstimulation syndrome: a retrospective study of OHSS risk and pregnancy rates. Atkinson P, Koch J, Ledger WL. Aust N Z J Obstet Gynaecol; 2014 Dec; 54(6):581-5. PubMed ID: 25476811 [Abstract] [Full Text] [Related]
13. Gonadotropin-releasing hormone agonist for ovulation trigger - OHSS prevention and use of modified luteal phase support for fresh embryo transfer. Castillo JC, Haahr T, Martínez-Moya M, Humaidan P. Ups J Med Sci; 2020 May; 125(2):131-137. PubMed ID: 32366146 [Abstract] [Full Text] [Related]
14. Intranasal gonadotropin-releasing hormone agonist (GnRHa) for luteal-phase support following GnRHa triggering, a novel approach to avoid ovarian hyperstimulation syndrome in high responders. Bar-Hava I, Mizrachi Y, Karfunkel-Doron D, Omer Y, Sheena L, Carmon N, Ben-David G. Fertil Steril; 2016 Aug; 106(2):330-3. PubMed ID: 27114332 [Abstract] [Full Text] [Related]
16. Oocyte maturation employing a GnRH agonist in combination with low-dose hCG luteal rescue minimizes the severity of ovarian hyperstimulation syndrome while maintaining excellent pregnancy rates. Radesic B, Tremellen K. Hum Reprod; 2011 Dec; 26(12):3437-42. PubMed ID: 21997895 [Abstract] [Full Text] [Related]
17. Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing hormone antagonist protocol in combination with a "freeze-all" strategy: a prospective multicentric study. Griesinger G, Schultz L, Bauer T, Broessner A, Frambach T, Kissler S. Fertil Steril; 2011 May; 95(6):2029-33, 2033.e1. PubMed ID: 21371705 [Abstract] [Full Text] [Related]